Tempus AI EPS - Earnings per Share 2023-2025 | TEM

Tempus AI annual and quarterly earnings per share history from 2023 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Tempus AI EPS for the quarter ending June 30, 2025 was $-0.25, a 96.36% decline year-over-year.
  • Tempus AI EPS for the twelve months ending June 30, 2025 was $1.45, a 113.92% decline year-over-year.
  • Tempus AI 2024 annual EPS was $-6.23, a 48.33% increase from 2023.
  • Tempus AI 2023 annual EPS was $-4.2, a 20.75% decline from 2022.
  • Tempus AI 2022 annual EPS was $-5.3, a 0% decline from .
Tempus AI Annual EPS
2024 $-6.23
2023 $-4.20
2022 $-5.30
Tempus AI Quarterly EPS
2025-06-30 $-0.25
2025-03-31 $-0.40
2024-12-31 $2.56
2024-09-30 $-0.46
2024-06-30 $-6.86
2024-03-31 $-1.47
2023-12-31 $-1.06
2023-09-30 $-1.03
2023-06-30 $-1.07
2023-03-31 $-1.04
2022-12-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $12.696B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.466B 59.12
Doximity (DOCS) United States $11.914B 53.01
Hims & Hers Health (HIMS) United States $9.534B 78.11
IRhythm Technologies (IRTC) United States $5.093B 0.00
Hinge Health (HNGE) United States $4.374B 0.00
Inspire Medical Systems (INSP) United States $2.663B 39.16
Privia Health (PRVA) United States $2.603B 192.82
Heartflow (HTFL) $2.489B 0.00
Enovis (ENOV) United States $1.740B 9.20
Phreesia (PHR) United States $1.681B 0.00
10x Genomics (TXG) United States $1.669B 0.00
Omnicell (OMCL) United States $1.466B 28.24
Schrodinger (SDGR) United States $1.428B 0.00
Azenta (AZTA) United States $1.388B 60.58
Clover Health Investments (CLOV) United States $1.292B 0.00
Claritev (CTEV) United States $1.115B 0.00
Evolent Health (EVH) United States $1.057B 0.00
Fulgent Genetics (FLGT) United States $0.660B 0.00
Zepp Health (ZEPP) Netherlands $0.568B 0.00
Veradigm (MDRX) United States $0.520B 0.00
Standard BioTools (LAB) United States $0.485B 0.00
Talkspace (TALK) United States $0.430B 128.50
Butterfly Network (BFLY) United States $0.347B 0.00
Carlsmed (CARL) $0.333B 0.00
TruBridge (TBRG) United States $0.293B 51.40
SOPHiA GENETICS SA (SOPH) Switzerland $0.237B 0.00
Outset Medical (OM) United States $0.237B 0.00
Nyxoah SA (NYXH) Belgium $0.214B 0.00
Health Catalyst (HCAT) United States $0.211B 0.00
KORU Medical Systems (KRMD) United States $0.190B 0.00
CapsoVision (CV) United States $0.182B 0.00
MDxHealth SA (MDXH) Belgium $0.137B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.119B 0.00
CareCloud (CCLD) United States $0.115B 5.23
American Well (AMWL) United States $0.115B 0.00
EUDA Health Holdings (EUDA) Singapore $0.086B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.074B 0.00
Pulmonx (LUNG) United States $0.062B 0.00
111 (YI) China $0.061B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
HeartBeam (BEAT) United States $0.038B 0.00
Zhongchao (ZCMD) China $0.024B 0.00
Precipio (PRPO) United States $0.023B 0.00
Healthcare Triangle (HCTI) United States $0.018B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
PROFUSA (PFSA) United States $0.003B 0.00